Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

Rong Fan; Hatice Satilmis; Niels Vandewalle; Elke De Bruyne; Eline Menu; Andrew D Chantry; Holly Evans; Marie Törngren; Helena  Eriksson; Karine Breckpot; Ken Maes; Karin Vanderkerken; Kim De Veirman

Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

Rong Fan, Hatice Satilmis, Niels Vandewalle, Elke De Bruyne, Eline Menu, Andrew D Chantry, Holly Evans, Marie Törngren, Helena Eriksson, Karine Breckpot, Ken Maes, Karin Vanderkerken, Kim De Veirman

Research output: Contribution to journal › Meeting abstract (Journal)

Original language	English
Pages (from-to)	651-651
Number of pages	1
Journal	Blood
Volume	138
Issue number	Supplement 1
Publication status	Published - 23 Nov 2021
Event	the 63rd ASH Annual Meeting and Exposition - Duration: 11 Dec 2021 → 14 Dec 2021

Cite this

Fan, R., Satilmis, H., Vandewalle, N., De Bruyne, E., Menu, E., D Chantry, A., Evans, H., Törngren, M., Eriksson, H., Breckpot, K., Maes, K., Vanderkerken, K., & De Veirman, K. (2021). Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo. Blood, 138(Supplement 1), 651-651.

Fan, Rong ; Satilmis, Hatice ; Vandewalle, Niels ; De Bruyne, Elke ; Menu, Eline ; D Chantry, Andrew ; Evans, Holly ; Törngren, Marie ; Eriksson, Helena ; Breckpot, Karine ; Maes, Ken ; Vanderkerken, Karin ; De Veirman, Kim. / Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo. In: Blood. 2021 ; Vol. 138, No. Supplement 1. pp. 651-651.

@article{1404a06e1e154163bd9264ee3503a1ed,

title = "Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo",

author = "Rong Fan and Hatice Satilmis and Niels Vandewalle and {De Bruyne}, Elke and Eline Menu and {D Chantry}, Andrew and Holly Evans and Marie T{\"o}rngren and Helena Eriksson and Karine Breckpot and Ken Maes and Karin Vanderkerken and {De Veirman}, Kim",

year = "2021",

month = nov,

day = "23",

language = "English",

volume = "138",

pages = "651--651",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "Supplement 1",

note = "the 63rd ASH Annual Meeting and Exposition ; Conference date: 11-12-2021 Through 14-12-2021",

}

Fan, R , Satilmis, H , Vandewalle, N , De Bruyne, E , Menu, E, D Chantry, A, Evans, H, Törngren, M, Eriksson, H, Breckpot, K , Maes, K , Vanderkerken, K & De Veirman, K 2021, 'Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo', Blood, vol. 138, no. Supplement 1, pp. 651-651.

Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo. / Fan, Rong ; Satilmis, Hatice ; Vandewalle, Niels ; De Bruyne, Elke ; Menu, Eline; D Chantry, Andrew; Evans, Holly; Törngren, Marie; Eriksson, Helena ; Breckpot, Karine ; Maes, Ken ; Vanderkerken, Karin ; De Veirman, Kim.

In: Blood, Vol. 138, No. Supplement 1, 23.11.2021, p. 651-651.

Research output: Contribution to journal › Meeting abstract (Journal)

TY - JOUR

T1 - Tasquinimod Targets Immunosuppressive Myeloid Cells, Increases Osteogenesis and Has Direct Anti-Myeloma Effects By Inhibiting c-Myc Expression in Vitro and In Vivo

AU - Fan, Rong

AU - Satilmis, Hatice

AU - Vandewalle, Niels

AU - De Bruyne, Elke

AU - Menu, Eline

AU - D Chantry, Andrew

AU - Evans, Holly

AU - Törngren, Marie

AU - Eriksson, Helena

AU - Breckpot, Karine

AU - Maes, Ken

AU - Vanderkerken, Karin

AU - De Veirman, Kim

PY - 2021/11/23

Y1 - 2021/11/23

M3 - Meeting abstract (Journal)

VL - 138

SP - 651

EP - 651

JO - Blood

JF - Blood

SN - 0006-4971

IS - Supplement 1

T2 - the 63rd ASH Annual Meeting and Exposition

Y2 - 11 December 2021 through 14 December 2021

ER -